Sending a specialist test to another laboratory creates a visible invoice. Bringing it in-house creates a less obvious collection of commitments: equipment, staff competence, quality controls, inventory and service continuity. The decision should compare complete supported services, including the practical consequences of low or uneven demand. It is an infrastructure assessment, with test selection remaining a matter for qualified clinical teams.

Count the relevant demand

A facility should distinguish requested tests, tests completed and tests likely to remain within its own service after expansion. A hypothetical laboratory may see attractive annual demand that arrives in small, irregular batches. That pattern can affect consumable use and staff scheduling. Demand assumptions should be checked with the requesting services, with new anticipated activity shown separately from an established record. A quoted volume from another institution cannot establish local utilisation simply because the same equipment model is proposed.

Price the complete local capability

The in-house case needs installation, technical support, staff time, quality activities and the consumables required at its expected workload. Pack sizes and shelf life can matter when activity is limited. The service should identify what happens during equipment failure or staff absence, because an external fallback may remain necessary after purchase. WHO's procurement and laboratory-quality resources support considering acquisition alongside the continuing quality system. The financial model should make these obligations visible instead of comparing an outsourced invoice with reagent cost alone.

External prices may include minimum charges or collection commitments that matter at low volumes. The comparison should show those conditions, so the institution can see whether occasional specialist work creates a continuing payment obligation even when few samples are sent.

Review the external service fairly

The alternative requires more than its test price. Collection arrangements, sample handling, reporting, communication and resolution of unsuitable submissions all affect its performance. A contract should define the accepted service and the responsibilities of both laboratories. Managers should also know which parts of elapsed time they control. An external laboratory cannot resolve a delay created before dispatch without a change at the originating facility. Keeping the boundary clear avoids rejecting a useful partnership because its invoice carries costs hidden within the local alternative.

Use a staged commitment

A facility can establish the decision thresholds before ordering equipment: supported demand, acceptable service time, staffing readiness and the expected continuing cash requirement. It may then review actual activity under an external arrangement while preparing any necessary local capability. The outcome need not be permanent; demand and support conditions can change. A documented comparison gives the next review a reliable starting point. The strongest purchase case explains why the local service can be sustained at realistic activity, rather than treating the removal of an external invoice as proof of savings.

References
  1. WHO — Laboratory quality management system handbook ↗
  2. WHO — Procurement process resource guide ↗